Samaritan Pharmaceuticals Begins Trading On OTC Bulletin Board Under Ticker Symbol SPHC
17 déc. 2007 10h10 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 17, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
Samaritan Pharmaceuticals to Trade On OTC Bulletin Board
13 déc. 2007 10h23 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 13, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (https://www.samaritanpharma.com), announces that it is seeking to have its common stock trade under a new stock...
Samaritan Pharma Retains The Investor Relations Group of New York
04 déc. 2007 10h51 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 4, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
Samaritan Presents Favorable Caprospinol Data At Alzheimer's Drug Development Summit November 30
27 nov. 2007 09h23 HE
|
Samaritan Pharmaceuticals, Inc.
Conference Showcases the Latest Disease Modifying Therapies and
Pre-Symptomatic Approaches for Alzheimer's Drug Development
Dr. Lecanu to Present Favorable Caprospinol Data Showing the Clearing
...
Samaritan Announces Update on Pharmaplaz Funding
09 nov. 2007 17h45 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 9, 2007 (PRIME NEWSWIRE) -- LAS VEGAS November 9, 2007--Samaritan Pharmaceuticals, Inc. (AMEX:LIV) announces that on October 16, 2007, Samaritan announced that it received $8.6 million...
Samaritan Expands Revenue Opportunities With Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
08 nov. 2007 10h20 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) is pleased to announce that its subsidiary, Samaritan Pharmaceuticals Europe, S.A., has received notification...
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
06 nov. 2007 10h38 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Nov. 6, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc., a developer of innovative drugs (AMEX:LIV), is honored to announce that Ms. Anna Strasberg has joined Samaritan's Advisory...
Samaritan Receives $8.6 Million Upfront Payment Under Commercialization Agreement for HIV Drug
16 oct. 2007 11h31 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that, under a March 9, 2007 agreement with Pharmaplaz, Ltd., a...
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
11 oct. 2007 09h52 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 11, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today it has signed an exclusive licensing and...
Samaritan Highlights Its Most Innovative HIV, Hepatitis C and Alzheimer's Drugs to Partner at Europe's Bio Partnering Conference
08 oct. 2007 09h22 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Oct. 8, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today its CEO Dr. Janet Greeson will highlight drugs in Samaritan's...